Pregnancy-Related Acute Kidney Injury in Preeclampsia: Risk Factors and Renal Outcomes.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 1 10 2019
medline: 21 11 2019
entrez: 1 10 2019
Statut: ppublish

Résumé

Preeclampsia is a common cause of acute kidney injury (AKI) in low- and middle-income countries, but AKI incidence in preeclampsia, its risk factors, and renal outcomes are unknown. A prospective observational multicenter study of women admitted with preeclampsia in South Africa was conducted. Creatinine concentrations were extracted from national laboratory databases for women with maximum creatinine of ≥90 μmol/L (≥1.02 mg/dL). Renal injury and recovery were defined by Kidney Disease Improving Global Outcomes creatinine criteria. Predefined risk factors, maternal outcomes, and neonatal outcomes were compared between AKI stages. Of 1547 women admitted with preeclampsia 237 (15.3%) met AKI criteria: 6.9% (n=107) stage 1, 4.3% (n=67) stage 2, and 4.1% (n=63) stage 3. There was a higher risk of maternal death (n=7; relative risk, 4.3; 95% CI, 1.6-11.4) and stillbirth (n=80; relative risk, 2.2; 95% CI, 1.8-2.8) in women with AKI compared with those without. Perinatal mortality was also increased (89 of 240; 37.1%). Hypertension in a previous pregnancy was the strongest predictor of AKI stage 2 or 3 (odds ratio, 2.24; 95% CI, 1.21-4.17). Renal recovery rate reduced with increasing AKI stage. A third of surviving women (76 of 230 [33.0%]) had not recovered baseline renal function by discharge. Approximately half (39 of 76; 51.3%) of these women had no further creatinine testing post-discharge. In summary, AKI was common in women with preeclampsia and had high rates of associated maternal and perinatal mortality. Only two-thirds of women had confirmed renal recovery. History of a previous hypertensive pregnancy was an important risk factor.

Identifiants

pubmed: 31564161
doi: 10.1161/HYPERTENSIONAHA.119.13089
pmc: PMC6791560
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1144-1151

Subventions

Organisme : Department of Health
ID : RP-2014-05-019
Pays : United Kingdom

Références

Sci Rep. 2018 Sep 28;8(1):14534
pubmed: 30266919
Nephron Clin Pract. 2010;115(2):c168-76
pubmed: 20407277
Kidney Int. 2012 Mar;81(5):477-85
pubmed: 22157656
Hypertens Pregnancy. 2010;29(4):457-67
pubmed: 20701467
BJOG. 2008 Jan;115(1):109-12
pubmed: 17970797
Ren Fail. 2010 Jan;32(3):309-13
pubmed: 20370445
Kidney Int. 2015 Nov;88(5):950-7
pubmed: 26221752
Curr Opin Crit Care. 2005 Dec;11(6):533-6
pubmed: 16292055
Blood Press Monit. 2015 Feb;20(1):52-5
pubmed: 25243711
Intensive Care Med. 2017 Jun;43(6):917-920
pubmed: 28213622
Ren Fail. 1996 Jul;18(4):575-84
pubmed: 8875682
Clin Nephrol. 1989 Jul;32(1):14-20
pubmed: 2788054
BMC Nephrol. 2018 Feb 2;19(1):25
pubmed: 29394890
Kidney Int. 2012 Mar;81(5):442-8
pubmed: 22113526
Best Pract Res Clin Obstet Gynaecol. 2019 May;57:47-59
pubmed: 30661950
J Nephrol. 2018 Feb;31(1):79-85
pubmed: 29302904
Nat Rev Nephrol. 2014 Apr;10(4):193-207
pubmed: 24445744
Clin J Am Soc Nephrol. 2012 Dec;7(12):2100-6
pubmed: 22879435
Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):169-74
pubmed: 16446026
Am J Perinatol. 2007 Nov;24(10):569-74
pubmed: 17909992
Intensive Care Med. 2017 Jun;43(6):855-866
pubmed: 28466146
Clin J Am Soc Nephrol. 2014 May;9(5):848-54
pubmed: 24578334
BMC Pregnancy Childbirth. 2017 Jul 18;17(1):235
pubmed: 28720086
J Nephrol. 2012 Jan-Feb;25(1):19-30
pubmed: 21928228
Hypertension. 2018 Aug;72(2):451-459
pubmed: 29915020
J Glob Health. 2018 Dec;8(2):020401
pubmed: 30140431
Am J Respir Crit Care Med. 2017 Mar 15;195(6):784-791
pubmed: 27635668
Hypertens Pregnancy. 2010;29(3):262-70
pubmed: 20670151
BMC Nephrol. 2017 May 1;18(1):146
pubmed: 28460634

Auteurs

Frances I Conti-Ramsden (FI)

From the Department of Women and Children's Health, King's College London, United Kingdom; (F.I.C-R., H.L.N., P.T.S., L.C.C., A.H.S., K.B.).

Hannah L Nathan (HL)

From the Department of Women and Children's Health, King's College London, United Kingdom; (F.I.C-R., H.L.N., P.T.S., L.C.C., A.H.S., K.B.).

Annemarie De Greeff (A)

Accuracy Assessed Medical Devices CC, Diamond, South Africa (A.D.g.).

David R Hall (DR)

Department of Obstetrics and Gynaecology, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa (D.R.H.).

Paul T Seed (PT)

From the Department of Women and Children's Health, King's College London, United Kingdom; (F.I.C-R., H.L.N., P.T.S., L.C.C., A.H.S., K.B.).

Lucy C Chappell (LC)

From the Department of Women and Children's Health, King's College London, United Kingdom; (F.I.C-R., H.L.N., P.T.S., L.C.C., A.H.S., K.B.).

Andrew H Shennan (AH)

From the Department of Women and Children's Health, King's College London, United Kingdom; (F.I.C-R., H.L.N., P.T.S., L.C.C., A.H.S., K.B.).

K Bramham (K)

From the Department of Women and Children's Health, King's College London, United Kingdom; (F.I.C-R., H.L.N., P.T.S., L.C.C., A.H.S., K.B.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH